X

Trial Profile

Phase II trial of Trastuzumab + CPT-11 therapy for HER2-positive advanced gastric cancer patients with prior chemotherapy

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 06 Jan 2020

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Irinotecan (Primary) ; Trastuzumab (Primary)
Indications Gastric cancer
Focus Therapeutic Use
Acronyms HERBIS-5

Most Recent Events

07 Aug 2016 Status changed from active, no longer recruiting to completed, according to results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
05 Aug 2013 Actual initiation date changed from Aug 2012 to 12 Oct 2012 as reported by University Hospital Medical Information Network - Japan record.
13 Aug 2012 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com